Lineage Cell Therapeutics director buys 25,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Lineage Cell Therapeutics, Inc. director Deborah J. Andrews purchased 25,000 common shares on November 16, 2026, at $0.80 per share. Her direct holdings after the purchase were 40,578 shares. No Rule 10b5-1 plan is reported for the purchase.
Insider Trade Summary
Net Buyer: 25,000 shares
Net Buy
1 txn
Insider
ANDREWS DEBORAH J
Role
Director
Bought
25,000 shs ($20K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Shares | 25,000 | $0.80 | $20K |
Holdings After Transaction:
Common Shares — 40,578 shares (Direct)
Key Figures
Shares purchased: 25,000 shares
Purchase price: $0.80 per share
Direct holdings after purchase: 40,578 shares
3 metrics
Shares purchased
25,000 shares
Direct purchase on November 16, 2026
Purchase price
$0.80 per share
Purchase on November 16, 2026
Direct holdings after purchase
40,578 shares
Reported following the November 16, 2026 purchase
Key Terms
Rule 10b5-1 plan
1 terms
Rule 10b5-1 plan regulatory
"No Rule 10b5-1 plan is reported for the purchase"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.